FRME
First Merchants Corporation
FRME's outlook is improving, though it still trails on the overall score.
JPM
JPMorgan Chase & Co.
JPM has the edge over FRME overall, supported by stronger fundamentals and stronger modeled upside.
FRME Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| N/A | |
| N/A |
FRME's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like FRME.
JPM Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
JPM's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like JPM.
FRME PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 8.8x | $28.35 | -31% |
| Forward | 9.7x | $40.94 | — |
| Fair | 11x | $35.18 | -14% |
| Expensive | 13x | $41.89 | +2.3% |
| Current | 13x | $40.94 | — |
Historical ranges are pointers, not guarantees.
FRME's PE is in its expensive range at 13x. If earnings grow as analysts expect, today's price would be 9.7x next year's earnings, in its fair range.
JPM PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.7x | $231 | -33% |
| Fair | 12x | $287 | -16% |
| Current | 14x | $343 | — |
| Forward | 14x | $343 | — |
| Expensive | 15x | $361 | +5.2% |
Historical ranges are pointers, not guarantees.
JPM has the edge over FRME in the historical PE scenario, which offers more potential upside but is not a forecast.
FRME Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Growth | |
| Growth | |
| Stable | |
| Limited | |
| High |
Analysts expect earnings and revenue growth for FRME, with profitability holding steady.
JPM Forward outlook
| Metric | Outlook |
|---|---|
| Stable | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for JPM, with profitability improving.
FRME Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $4.21 | +31% |
| Q3 2026 | $3.22 | -19% |
| Q2 2026 | $3.11 | -19% |
| Q1 2026 | $3.39 | -4.5% |
| Q4 2025 | $3.88 | +14% |
| Q3 2025 | $3.99 | +32% |
| Q2 2025 | $3.85 | +23% |
| Q1 2025 | $3.55 | +2.6% |
| Q4 2024 | $3.41 | -8.6% |
FRME's earnings per share have fallen from their peak: $3.22 over the past year, against $4.36 in mid-2023.
JPM Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $24.99 | +4.8% |
| Q3 2026 | $23.85 | +18% |
| Q2 2026 | $23.35 | +20% |
| Q1 2026 | $20.89 | +2.5% |
| Q4 2025 | $20.02 | +1.4% |
| Q3 2025 | $20.20 | +12% |
| Q2 2025 | $19.50 | +8.7% |
| Q1 2025 | $20.38 | +23% |
| Q4 2024 | $19.75 | +22% |
JPM has the edge over FRME on earnings, with more consistent year-over-year improvement.
FRME Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $199.1M | +20% |
| Q2 2026 | $196.1M | +19% |
| Q1 2026 | $157.1M | -2% |
| Q4 2025 | $172.2M | -2.8% |
| Q3 2025 | $166.1M | +6.5% |
| Q2 2025 | $164.3M | +2.8% |
| Q1 2025 | $160.3M | +4.3% |
| Q4 2024 | $177.1M | +13% |
FRME's revenue has picked up after two years of holding roughly level: $199M last quarter, up 20% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 40% | +0.6 points |
| Q2 2026 | 24% | -15 points |
| Q1 2026 | 17% | -22 points |
| Q4 2025 | 38% | -5.2 points |
| Q3 2025 | 39% | +3.2 points |
| Q2 2025 | 40% | +12 points |
| Q1 2025 | 39% | +3.8 points |
| Q4 2024 | 43% | +13 points |
FRME's operating margin was 40% last quarter, up 0.6 points from the same quarter a year ago.
JPM Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $50.2B | +8.1% |
| Q2 2026 | $57.3B | +28% |
| Q1 2026 | $49.8B | +10% |
| Q4 2025 | $45.8B | +7.1% |
| Q3 2025 | $46.4B | +8.8% |
| Q2 2025 | $44.9B | -11% |
| Q1 2025 | $45.3B | +8.1% |
| Q4 2024 | $42.8B | +11% |
JPM has the edge over FRME on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 40% | -0.2 points |
| Q2 2026 | 48% | +7.3 points |
| Q1 2026 | 41% | +0.5 points |
| Q4 2025 | 37% | -3.2 points |
| Q3 2025 | 40% | +0.6 points |
| Q2 2025 | 41% | -6 points |
| Q1 2025 | 41% | -0.6 points |
| Q4 2024 | 41% | +11 points |
JPM has the edge over FRME on profitability, with a higher operating margin.
FRME Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $78.4M | -10% |
| Q2 2026 | $88M | +64% |
| Q1 2026 | $58.6M | -5% |
| Q4 2025 | $80.7M | +20% |
| Q3 2025 | $87.6M | +14% |
| Q2 2025 | $53.7M | -15% |
| Q1 2025 | $61.7M | +4.8% |
| Q4 2024 | $67.5M | -22% |
FRME has the edge over JPM on cash generation, producing positive trailing cash flow while its opponent burns cash.
JPM Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $33.2B | +$78.4B |
| Q2 2026 | -$25.3B | -186% |
| Q1 2026 | -$211.8B | +$40.1B |
| Q4 2025 | $119.7B | -19% |
| Q3 2025 | -$45.2B | +$28.9B |
| Q2 2025 | $29.5B | -23% |
| Q1 2025 | -$251.8B | -$97.7B |
| Q4 2024 | $147.8B | +145% |
JPM's free cash flow was −$84.2B over the past year, against −$120B the year before. Free cash flow isn't a meaningful measure for financial services companies like JPM.
FRME Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.3% | -163K shares |
| 1 year | +8.6% | +5M shares |
| 3 years | +4.9% | +2.9M shares |
| 5 years | +16% | +8.5M shares |
| Available history | +12% | +6.9M shares |
FRME has 62M diluted shares, up 8.6% from a year ago, despite $61M in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q3 2026 | $12M |
| Q2 2026 | $13.4M |
| Q1 2026 | $24.9M |
| Q4 2025 | $10.4M |
| Q3 2025 | $6.5M |
| Q2 2025 | $22.1M |
| Q1 2025 | $7.9M |
| Q4 2024 | $6.2M |
FRME spent $61M buying back its own shares over the past year, up 42% from the year before.
JPM Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -11.2M shares |
| 1 year | -3.1% | -84.6M shares |
| 3 years | -8.5% | -249M shares |
| 5 years | -11% | -322M shares |
| Available history | -17% | -547M shares |
JPM has the edge over FRME on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $1.1B |
| Q2 2026 | $6.8B |
| Q1 2026 | $8.3B |
| Q4 2025 | $8.3B |
| Q3 2025 | $8.3B |
| Q2 2025 | $7.5B |
| Q1 2025 | $7.5B |
| Q4 2024 | $4.3B |
JPM spent $24.5B buying back its own shares over the past year, down 11% from the year before.
FRME Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 4.0x | Elevated |
| Q2 2026 | 6.0x | High |
| Q1 2026 | 5.1x | High |
| Q4 2025 | 2.7x | Moderate |
| Q3 2025 | 2.5x | Moderate |
| Q2 2025 | 3.0x | Moderate |
| Q1 2025 | 3.5x | Elevated |
| Q4 2024 | 3.2x | Elevated |
FRME's net debt is about 4.0 years of its operating earnings (EBITDA), up from 2.5 years a year ago. Net leverage isn't a meaningful measure for financial services companies like FRME.
JPM Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.5x | Very low |
| Q2 2026 | 0.5x | Very low |
| Q1 2026 | 0.6x | Very low |
| Q4 2025 | 0.5x | Very low |
| Q3 2025 | 0.6x | Very low |
| Q2 2025 | 0.5x | Very low |
| Q1 2025 | 0.5x | Very low |
| Q4 2024 | 0.4x | Very low |
JPM has the edge over FRME on leverage, with a lower net debt burden relative to earnings.
FRME Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 50.0 | Neutral |
| Stochastic | 42.5 | Neutral |
FRME's weekly RSI is 50 (neutral) and its Stochastic is 43 (neutral).
JPM Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 54.8 | Neutral |
| Stochastic | 31.5 | Neutral |
JPM's weekly RSI is 55 (neutral) and its Stochastic is 31 (neutral).
FRME PE vs Financial Services Sector
| Metric | FRME | Sector median | Relative |
|---|---|---|---|
| PE | 13x | 13x | 2.4% below |
| PE % | 79 | 63 | 16 pts above |
FRME has the edge over JPM on valuation relative to its sector.
JPM PE vs Financial Services Sector
| Metric | JPM | Sector median | Relative |
|---|---|---|---|
| PE | 14x | 13x | 10% above |
| PE % | 76 | 63 | 13 pts above |
JPM is trading at 14x earnings, a 10% premium to the Financial Services sector's median of 13x.
FRME Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $40.3 | 1.6% above |
| 20 week MA | $41.7 | 1.8% below |
| 50 week MA | $40.4 | 1.3% above |
| 100 week MA | $39.7 | 3.2% above |
| 200 week MA | $36.9 | 11% above |
FRME's trend is mixed: it's above four of its five weekly moving averages, and 11% above its 200-week average.
JPM Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $336.8 | 1.8% above |
| 20 week MA | $345.3 | 0.7% below |
| 50 week MA | $323.2 | 6.1% above |
| 100 week MA | $298.9 | 15% above |
| 200 week MA | $236.6 | 45% above |
JPM's trend is mixed: it's above four of its five weekly moving averages, and 45% above its 200-week average.
FRME Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $41.3 | $36.8 | -11% |
| 2021 | $36.8 | $41.2 | +12% |
| 2022 | $41.2 | $40.5 | -1.6% |
| 2023 | $40.5 | $37.1 | -8.5% |
| 2024 | $37.1 | $40.3 | +8.5% |
| 2025 | $40.3 | $38.3 | -4.9% |
| 2026 YTD | $38.3 | $40.9 | +7% |
FRME has the edge over JPM on returns for 2026, with the stronger performance.
JPM Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $139.1 | $124.5 | -11% |
| 2021 | $124.5 | $157.3 | +26% |
| 2022 | $157.3 | $131.3 | -17% |
| 2023 | $131.3 | $170.1 | +30% |
| 2024 | $170.1 | $241.2 | +42% |
| 2025 | $241.2 | $327.9 | +36% |
| 2026 YTD | $327.9 | $342.8 | +4.5% |
JPM has finished higher in four of the last six years. It's up 4.5% so far in 2026.